Frequency and Risk Factors for Hematoma Formation Following Bone Marrow Biopsy in Patients with Severe and Very Severe Thrombocytopenia

Authors

  • Ayesha Bangash Hayatabad Medical Complex, Peshawar
  • Fawad Rahim Hayatabad Medical Complex / Khyber Girls Medical College, Peshawar.
  • Sheema Tariq Hayatabad Medical Complex, Peshawar
  • Khushal Nadir Hadi Hayatabad Medical Complex, Peshawar
  • Sobia Ahmed Qureshi Hayatabad Medical Complex, Peshawar
  • Ayesha Hamid Hayatabad Medical Complex, Peshawar, Pakistan
  • Gul E Lala Noman Hayatabad Medical Complex, Peshawar

DOI:

https://doi.org/10.37762/jgmds.12-3.723

Keywords:

Bone marrow, Biopsy, Thrombocytopenia, Hematoma, Bleeding, Risk factors, Pakistan

Abstract

OBJECTIVES

To determine the frequency and risk factors of hematoma formation after bone marrow biopsy in patients with severe and very severe thrombocytopenia.

METHODOLOGY

This cross-sectional study was conducted at Hayatabad Medical Complex, Peshawar, from 1st April 2024 to 31st January 2025. Patients over the age of 18 years with severe and very severe thrombocytopenia who underwent bone marrow biopsy were included. Age, gender, clinical bleeding at presentation, history of bone marrow biopsy at the same site, body mass index, and platelet count at the time of biopsy were documented. Participants were screened for hematoma twenty-four hours after the procedure. Data analysis was carried out in SPSS.

RESULTS
Most patients had severe thrombocytopenia (60.3%, n = 132), while the remaining patients had very severe thrombocytopenia (39.7%, n = 87). Only eight patients (3.7%) developed a hematoma. Patients who had clinical bleeding (95% CI: 1.93 – 168.45; p = 0.011) and who had repeat biopsy from a site of previous biopsy (AOR: 18.03; 95% CI: 1.93 – 168.45; p = 0.011) were significantly more likely to develop hematoma. The development of hematoma was not influenced by age, gender, body mass index, or the severity of thrombocytopenia.

CONCLUSION

Hematoma formation after bone marrow biopsy is uncommon. Patients with clinical bleeding and previous biopsy at the same site have a higher risk. Factors like age, gender, body mass index, and severity of thrombocytopenia did not significantly impact hematoma formation. Prophylactic platelet transfusion before bone marrow biopsy may largely be unnecessary and can be avoided. 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Ayesha Bangash, Hayatabad Medical Complex, Peshawar

Postgraduate Resident, Department of Medicine,
Hayatabad Medical Complex, Peshawar

Fawad Rahim, Hayatabad Medical Complex / Khyber Girls Medical College, Peshawar.

Associate Professor,
Department of Medicine, Hayatabad Medical
Complex, Peshawar, Pakistan

Sheema Tariq, Hayatabad Medical Complex, Peshawar

Postgraduate Resident,
Department of Medicine,
Hayatabad Medical Complex, Peshawar

Khushal Nadir Hadi, Hayatabad Medical Complex, Peshawar

Postgraduate Resident, Department of Medicine,
Hayatabad Medical Complex, Peshawar

Sobia Ahmed Qureshi, Hayatabad Medical Complex, Peshawar

Postgraduate Resident,
Department of Medicine,
Hayatabad Medical Complex, Peshawar

Gul E Lala Noman, Hayatabad Medical Complex, Peshawar

Postgraduate Resident, Department of Medicine,
Hayatabad Medical Complex, Peshawar

References

Dogan A, Demircioglu S. Diagnostic importance of bone marrow aspiration evaluation: A single-center study. Pakistan J Med Sci. 2022;38(4 SE-Original Articles). https://doi.org/10.12669/pjms.38.4.4797 DOI: https://doi.org/10.12669/pjms.38.4.4797

Obasi JU, Umpierrez De Reguero AP. Safety Profile of Bone Marrow Aspiration and Biopsies Performed By the Hospitalist Procedure Service at an Academic Center: An Observational Study. Blood. 2019;134(Supplement_1):5848. https://doi.org/10.1182/blood-2019-121444 DOI: https://doi.org/10.1182/blood-2019-121444

Tomasian A, Jennings J. Bone marrow aspiration and biopsy: techniques and practice implications. Skeletal Radiol. 2021;51:81-88. https://doi.org/10.1007/s00256-021-03882-w DOI: https://doi.org/10.1007/s00256-021-03882-w

Bain BJ. Bone marrow biopsy morbidity: review of 2003. J Clin Pathol. 2005;58(4):406 LP - 408. https://doi.org/10.1136/jcp.2004.022178 DOI: https://doi.org/10.1136/jcp.2004.022178

Bain BJ. Bone marrow biopsy morbidity and mortality. Br J Haematol. 2003;121(6):949-951. https://doi.org/https://doi.org/10.1046/j.1365-2141.2003.04329.x DOI: https://doi.org/10.1046/j.1365-2141.2003.04329.x

Salem P, Wolverson MK, Reimers HJ, Kudva GC. Complications of bone marrow biopsy. Br J Haematol. 2003;121(6):821. https://doi.org/10.1046/j.1365-2141.2003.04328.x DOI: https://doi.org/10.1046/j.1365-2141.2003.04328.x

Moore C, Kotchetkov R. Anticoagulation and bone marrow biopsy: is it safe to proceed? Hematology. 2021;26:206-209. https://doi.org/10.1080/16078454.2021.1880762 DOI: https://doi.org/10.1080/16078454.2021.1880762

Grange L, Killian M, Tavernier E, Fouillet L, Guyotat D, Chalayer E. Management of bone marrow biopsy related bleeding risks: a retrospective observational study. J Thromb Thrombolysis. 2021;54:109-114. https://doi.org/10.1007/s11239-021-02616-y DOI: https://doi.org/10.1007/s11239-021-02616-y

Hyun BH, Gulati GL, Ashton JK. Bone marrow examination: techniques and interpretation. Hematol Oncol Clin North Am. 1988;2(4):513-523. https://doi.org/10.1016/S0889-8588(18)30581-1 DOI: https://doi.org/10.1016/S0889-8588(18)30581-1

Ellis LD, Jensen WN, Westerman MP. Needle biopsy of bone and marrow: An experience with 1,445 biopsies. Arch Intern Med. 1964;114:213-221. https://doi.org/10.1001/archinte.1964.03860080063005 DOI: https://doi.org/10.1001/archinte.1964.03860080063005

Rebulla P. Platelet transfusion trigger in difficult patients. Transfus Clin Biol J la Soc Fr Transfus Sang. 2001;8(3):249-254. https://doi.org/10.1016/s1246-7820(01)00129-x DOI: https://doi.org/10.1016/S1246-7820(01)00129-X

Eikelboom JW. Bone marrow biopsy in thrombocytopenic or anticoagulated patients. Br J Haematol. 2005;129(4):562-563. https://doi.org/10.1111/j.1365-2141.2005.05494.x DOI: https://doi.org/10.1111/j.1365-2141.2005.05494.x

Stensby JD, Long JR, Hillen TJ, Jennings JW. Safety of bone marrow aspiration and biopsy in severely thrombocytopenic patients. Skeletal Radiol. 2021;50(5):915-920. https://doi.org/10.1007/s00256-020-03623-5 DOI: https://doi.org/10.1007/s00256-020-03623-5

Sarigianni M, Vlachaki E, Chissan S, Klonizakis F, Vetsiou E, Anastasiadou KI, et al. Haematoma Caused by Bone Marrow Aspiration and Trephine Biopsy. Hematol Rep. 2011;3(3). https://doi.org/10.4081/hr.2011.e25 DOI: https://doi.org/10.4081/hr.2011.e25

Badiola CM, Scappaticci F, Brahaj D. CT Guided Bone Marrow Aspiration and Core Biopsy. Open J Radiol. 2012;2:55-56. https://doi.org/10.4236/ojrad.2012.22010 DOI: https://doi.org/10.4236/ojrad.2012.22010

Morley NJ, Makris M. Bone marrow biopsy related haemorrhage and low molecular weight heparin. Br J Haematol. 2003;123(3):562. https://doi.org/10.1046/j.1365-2141.2003.04648.x DOI: https://doi.org/10.1046/j.1365-2141.2003.04648.x

Manchec Joseph; Liu, Bo; Pepe, Julie W; Burt, Jeremy; Contreras, Francisco; Ward, Thomas J. BL. Safety and Technical Success of CT-Guided Bone Marrow Biopsy in Obese Patients. J Clin Interv Radiol ISVIR. 2020;4(01):16-19. https://doi.org/10.1055/s-0039-3401330 DOI: https://doi.org/10.1055/s-0039-3401330

Story E, Klaassen R, Johnston DL. Iliopsoas hematoma following a bone marrow aspirate. Pediatr Blood Cancer. 2008;51(1):146. https://doi.org/10.1002/pbc.21546 DOI: https://doi.org/10.1002/pbc.21546

Downloads

Published

2025-06-30

How to Cite

Bangash, A., Rahim, F., Tariq, S., Hadi, K. N., Qureshi, S. A., Hamid, A., & Noman, G. E. L. (2025). Frequency and Risk Factors for Hematoma Formation Following Bone Marrow Biopsy in Patients with Severe and Very Severe Thrombocytopenia. Journal of Gandhara Medical and Dental Science, 12(3), 12–16. https://doi.org/10.37762/jgmds.12-3.723